Sign in

CIK 0001355790

  • Non-accelerated filer
  • Smaller reporting company

International Stem Cell CORP

Sign in to watch
Ticker
ISCO
Exchange
OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
204494098
Phone
+1 760-940-6383
Business address
9745 BUSINESSPARK AVENUE, SAN DIEGO, CA, 92131
Former names
BTHC III INC.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$10,497
in 1 filing

Net −$10,497. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. MAIER PAUL V −$10K Director sold 100% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2015-03-12 Bakalova Sofya Vice President Grant or award · Stock Option (Right to Buy) +200,000 200,000
2015-03-06 CASAMENTO CHARLES J Director Grant or award +76,958 571,611
2015-02-23 Semechkin Ruslan Chief Scientific Officer Purchase +1,861,331 $0.04 $83K 7,541,384
2015-02-23 Semechkin Ruslan Chief Scientific Officer Option exercise · Series B Warrant (Right to Buy) −1,861,331 0
2014-12-22 Semechkin Andrey Chief Executive Officer Purchase +5,894,214 $0.06 $340K 54,249,307
2014-12-22 Semechkin Andrey Chief Executive Officer Option exercise · Series B Warrant (Right to Buy) −5,894,214 0
2014-11-10 Semechkin Ruslan Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +60,000 60,000
2014-11-10 Semechkin Andrey Chief Executive Officer Grant or award · Stock Option (Right to Buy) +60,000 60,000
2014-11-10 Novak Tibor Jay Chief Financial Officer Grant or award · Stock Option (Right to Buy) +60,000 60,000
2014-11-10 Craw John Simon Executive Vice President Grant or award · Stock Option (Right to Buy) +60,000 60,000
2014-11-10 Bakalova Sofya Vice President Grant or award · Stock Option (Right to Buy) +60,000 60,000
2014-10-14 Semechkin Andrey Chief Executive Officer Purchase · Series H-2 Preferred Stock +380 $1,000.00 $380K 380
2014-10-14 Semechkin Andrey Chief Executive Officer Purchase · Series A Warrant (Right to Buy) +5,894,214 5,894,214
2014-10-14 Semechkin Andrey Chief Executive Officer Purchase · Series B Warrant (Right to Buy) +5,894,214 5,894,214
2014-10-14 Semechkin Andrey Chief Executive Officer Purchase · Series C Warrant (Right to Buy) +5,894,214 5,894,214
2014-10-14 Semechkin Ruslan Chief Scientific Officer Purchase · Series H-2 Preferred Stock +120 $1,000.00 $120K 120
2014-10-14 Semechkin Ruslan Chief Scientific Officer Purchase · Series A Warrant (Right to Buy) +1,861,331 1,861,331
2014-10-14 Semechkin Ruslan Chief Scientific Officer Purchase · Series B Warrant (Right to Buy) +1,861,331 1,861,331
2014-10-14 Semechkin Ruslan Chief Scientific Officer Purchase · Series C Warrant (Right to Buy) +1,861,331 1,861,331
2014-10-10 Novak Tibor Jay Chief Financial Officer Purchase +10,000 $0.10 $1K 40,000

Page 12 of 15 · 298 trades